» Articles » PMID: 23888903

Agreement of the Serum Spec FPL™ and 1,2-o-dilauryl-rac-glycero-3-glutaric Acid-(6'-methylresorufin) Ester Lipase Assay for the Determination of Serum Lipase in Cats with Suspicion of Pancreatitis

Overview
Date 2013 Jul 30
PMID 23888903
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Serum lipase activities measured by catalytic assays are claimed to be of limited utility for diagnosing pancreatitis in cats. The Spec fPL assay currently is believed the most sensitive test; however, studies comparing different lipase assays are lacking. 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) assay for the determination of lipase activity has been evaluated in dogs, but no information is available in cats.

Objectives: To investigate the agreement of DGGR-lipase activity and Spec fPL concentration in cats with clinical signs consistent with pancreatitis.

Animals: Two hundred fifty-one client-owned cats.

Methods: DGGR-lipase activity and Spec fPL concentration measured from the same blood sample in cats undergoing investigation for pancreatitis. The agreement between DGGR-lipase and Spec fPL at different cutoffs was assessed using Cohen's kappa coefficient (κ). Sensitivity and specificity were calculated for 31 cases where pancreatic histopathology was available.

Results: DGGR-lipase (cutoff, 26 U/L) and Spec fPL (cutoff, >5.3 μg/L) had a κ of 0.68 (standard error [SE] 0.046). DGGR-lipase (cutoff, 26 U/L) and Spec fPL (cutoff, >3.5 μg/L) had a κ of 0.60 (SE, 0.05). The maximum κ at a Spec fPL cutoff >5.3 μg/L was found when the DGGR-lipase cutoff was set >34 U/L and calculated as 0.755 (SE, 0.042). Sensitivity and specificity were 48% and 63% for DGGR-lipase (cut-off, 26 U/L) and 57% and 63% for Spec fPL (>5.3 μg/L), respectively.

Conclusions And Clinical Importance: Both lipase assays agreed substantially. DGGR assay seems a useful and cost-efficient method compared to the Spec fPL test.

Citing Articles

Signalment, clinicopathological findings, management practices and comorbidities in cats with diabetes mellitus in Germany: cross-sectional study of 144 cases.

Guse B, Langenstein J, Bauer N, Hazuchova K J Feline Med Surg. 2025; 27(1):1098612X241303303.

PMID: 39772828 PMC: 11707777. DOI: 10.1177/1098612X241303303.


Evaluation of laboratory findings indicating pancreatitis in healthy lean, obese, and diabetic cats.

Jorgensen F, Bjornvad C, Krabbe B, Nybroe S, Kieler I J Vet Intern Med. 2024; 39(1):e17236.

PMID: 39545314 PMC: 11627516. DOI: 10.1111/jvim.17236.


Evaluation of Disease Spectrum in Hospitalized Cats with Hyperlipasemia: Pancreatitis Alone Is Rare, Hyperlipasemia without Suspected Pancreatitis Is Common.

Hotz V, Brugger D, Kook P Animals (Basel). 2024; 14(10).

PMID: 38791696 PMC: 11117254. DOI: 10.3390/ani14101479.


Effects of prednisolone on 1,2-O-dilauryl-rac-glycero glutaric acid-(60-methylresorufin) ester-lipase activity and pancreatic lipase immunoreactivity in healthy cats.

Pacheva M, Brugger D, Riond B, Dennler M, Kook P J Vet Intern Med. 2024; 38(3):1370-1376.

PMID: 38485220 PMC: 11099763. DOI: 10.1111/jvim.17042.


Specificity of a pancreatic lipase point-of-care test and agreement with pancreatic lipase immunoreactivity in cats without clinical evidence of pancreatitis.

Xenoulis P, Moraiti K, Spanou V, Chatzis M, Kokkinaki K, Saridomichelakis M J Feline Med Surg. 2023; 25(7):1098612X231183299.

PMID: 37498286 PMC: 10812057. DOI: 10.1177/1098612X231183299.